Related Experiment Video

Updated: Aug 8, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
09:37

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

Does interferon improve portal hypertension?

Diego Rincón1, Cristina Ripoll, María Vega Catalina

  • 1Hospital General Universitario Gregorio Marañón Dr Esquerdo 46, 28007, Madrid, Spain.

The Journal of Antimicrobial Chemotherapy
|May 25, 2006
PubMed

Insights

Antiviral therapy may improve liver disease in chronic hepatitis C patients, potentially reducing portal hypertension (PHT). Further research is needed to confirm these effects on liver fibrosis and PHT management.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Virology

Background:

  • Chronic hepatitis C is a primary cause of advanced liver disease and cirrhosis globally.
  • Portal hypertension (PHT) is a common complication of cirrhosis, leading to severe outcomes and liver transplantation.
  • Antiviral therapy (AVT) shows potential benefits for liver inflammation and fibrosis, independent of viral clearance.

Purpose of the Study:

  • To review the impact of AVT on portal hypertension (PHT) in advanced chronic hepatitis C.
  • To explore the implications of AVT-induced histological changes on PHT.
  • To discuss clinical practice and future research directions regarding AVT and PHT.

Main Methods:

  • Literature review of studies investigating AVT in chronic hepatitis C patients with advanced liver disease.
  • Analysis of data on histological changes, liver inflammation, fibrosis, and portal hypertension.
  • Synthesis of findings on the relationship between AVT, histological improvements, and PHT.

Main Results:

  • AVT may exert beneficial effects on liver histology, including inflammation and fibrosis.
  • The influence of these histological changes on portal hypertension (PHT) is under investigation.
  • Evidence suggests a potential, albeit not fully elucidated, impact of AVT on PHT.

Conclusions:

  • AVT may offer benefits beyond viral eradication, potentially impacting PHT in chronic hepatitis C.
  • Further research is crucial to understand the mechanisms and clinical significance of AVT's effect on PHT.
  • Investigating AVT's role in managing PHT could refine treatment strategies for advanced liver disease.

More Related Videos

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension04:00

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Published on: November 15, 2024

Related Concept Videos

Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...